This study sought to assess the possible significance of the adipokine CTRP5, which has been inadequately explored in relation to CAD and the adipokine chemerin in differentiating between individuals with CCTA-confirmed normal coronary arteries and patients with CCTA-confirmed CAD. This evidence concerns the gene C1QTNF5 and coronary artery disorder.